The Sound of Survival, and the Silence of Survivorship

In most pediatric hospital wings, there is a brass bell at the end of a hallway. When a child finishes chemotherapy, staff gather, families and friends cheer, and the child triumphantly rings the bell to signal their hard-fought victory. I was five when I finished my treatment and, despite being too young to remember ringing my own bell, I grew up with those images. They captured the joy of finishing cancer treatment, but not the longer story that tends to follow.

People love a clear ending, a day when cancer is “over.” Childhood cancer survivorship rarely works that way. In my medical charts, cancer now sits under “past medical history.” Outside a hospital setting, friends see a healthy young adult in graduate school. What those snapshots miss is the long shadow of treatment and the late effects that follow survivors into their teens, twenties, and beyond.

The United States treats remission like a finish line. Once the hair grows back, childhood cancer survivors disappear from public view. That disappearance hides a long public health story about chronic disease, mental health, and unequal access to care.

Even in the years beyond remission, clean scans and absent symptoms still leave room for a quiet fear that cancer may one day return.

While childhood cancer is rare compared with adult cancers, it carries the same heavy burden across a lifetime. Survival rates have improved significantly for many pediatric cancers over the past several decades. This also means there is a growing population of childhood cancer survivors in the United States living with higher risks of heart disease, endocrine problems, second cancers, and mental health conditions. These are not individual quirks of biology. They are predictable consequences of intensive treatment delivered to young, developing bodies.

The National Cancer Institute reports that 60% to more than 90% of child survivors develop at least one chronic health condition, and many face a greater risk of severe or life-threatening complications in adulthood. Chest radiation and certain chemotherapy drugs increase the risk of early heart failure. Other treatments disrupt hormones, stunt growth, or weaken bones.

Some survivors discover that their chance to have biological children was taken away years before they were old enough to think about their desire to have children. Brain-directed therapies can affect focus and memory, shaping school performance and job prospects. Anxiety, depression, and post-traumatic stress are more common among childhood cancer survivors than among peers. Even in the years beyond remission, clean scans and absent symptoms still leave room for a quiet fear that cancer may one day return.

I feel these patterns in my own life. On new patient forms, “childhood cancer” appears as one small check box, yet it shapes nearly every medical choice I make. Pediatric cancer survivors are often asked to become lifelong managers of risks they did not choose and may still be learning to understand. That burden feels more real to me now as I age out of pediatric care and move into a medical system where the handoff is not always smooth, and where survivors are often left to carry the memory of their history on their own.

The bell at the end of the hallway marks a moment people can see and celebrate. For survivors, it is not the end of the story.

The health care system is not designed around this long arc of need. Some survivors receive care in dedicated survivorship clinics that coordinate screening and connect them with specialists. Many never do. Survivors from low-income families, those in rural areas, and survivors of color face more barriers to specialist care and experience worse outcomes. Additionally, once survivors age out of pediatric care, they often lose contact with the teams that know their history best. Adult primary care clinicians may not have the training or guidelines at hand to manage the complex screening schedules childhood cancer survivors require.

Public attention follows a similar pattern. Each September, childhood cancer campaigns fill social media with photos of bald heads and brave smiles. These images raise money and awareness, which matters. But they also paint a narrower story about what survivorship looks like. The image most people remember is the celebration at the end of treatment. What survivors carry forward is often less visible: chronic risk, follow-up care, and the lasting effects of what it took to survive. Funding and research priorities tilt toward new drugs and technologies, while survivorship research, mental health services, fertility care, and long-term follow-up clinics receive a smaller share of investment.

Childhood cancer survivors carry elevated risks of heart disease, second cancers, infertility, and mental health conditions that add to the broader burden of chronic illness and disability. Treating survivorship as a public health priority would help expand early screening and long-term support while reducing inequities in outcomes.

The bell at the end of the hallway marks a moment people can see and celebrate. For survivors, it is not the end of the story. It is the beginning of a lifetime of care that our health system and our public imagination are only beginning to acknowledge.

The views expressed here are the author’s own and do not necessarily represent the views of Public Health Post or Boston University School of Public Health.